A preparation extracted from human blood platelets, which incorporates 32p from -y-labeled AT32P into one of the two light chains of platelet myosin and platelet myosin head is described. This phosphorylation, which appears to be due to an endogenous kinase, is specific for the myosin light chain in that no other protein extracted in 0.6 M KCI-15 mM Tris HCI (pH 7.5) is phosphorylated. The phosphorylated light chain, which has been purified by gel filtration, releases the covalently bound phosphate after incubation in alkali and not after incubation in acid.
Human blood platelets contain three proteins which are similar to muscle contractile proteins. These proteins, platelet myosin, platelet actin, and platelet tropomyosin, have been purified and characterized so that their structure and function can be compared to muscle contractile proteins (1) (2) (3) .
Platelet myosin is similar to muscle myosin in being composed of two heavy chains (molecular weight 200,000) and two different light chains (molecular weight 20 ,000 and 15,000). Moreover platelet myosin can be digested by proteolytic enzymes to yield two fragments, rod and head (1, 4) . These fragments have similar properties to the rod and subfragment-1 fragments produced by proteolytic cleavage of skeletal-muscle myosin (5) .
Functionally, platelet myosin and platelet myosin head bind to platelet and skeletal muscle actin and are dissociated from it by ATP. At low ionic strength, in the presence of Mg2+, the ATPase activity of platelet myosin head is activated by rabbit muscle actin. This activation is dependent on Ca2+ in the presence of muscle troponin-tropomyosin (1) .
Platelet actin, which resembles skeletal muscle actin in molecular weight and ability to undergo a G F (globular fibrous) transformation, activates the ATPase activity of of skeletal-muscle heavy meromyosin. This activation becomes Ca2+-dependent after the addition of rabbit skeletalmuscle troponin-tropomyosin (1) . The third contractile protein, platelet tropomyosin, which resembles muscle tropomyosin in several physical and chemical properties, has a molecular weight lower than muscle tropomyosin. This protein has been isolated and characterized by Cohen and Cohen (2) .
The manner by which the interaction of platelet actin and myosin (as well as actin and myosin from cells other than platelets) is regulated is of current interest. One manner of control of this interaction might be through a troponintropomyosin complex, similar to that present in skeletalmuscle proteins. Only indirect evidence points to the existence of such a system in platelets (1, 2) . Reversible phosphorylation of one of the contractile proteins offers another possible control mechanism for platelet contraction and/or aggrega-3115 tion. This is of particular interest, since a protein kinase has been isolated from platelets but the substrate for this kinase has yet to be identified (6) .
In this paper we describe a preparation extracted from washed, human platelets which incorporates 82p from -ylabeled AT32P into the light chain of molecular weight 20,000 of platelet myosin. This preparation, which apparently contains an endogenous kinase, does not incorporate 32p from ATP into the other platelet contractile proteins, nor into any other protein extracted in 0.6 M KCl from platelets.
MATERIALS AND METHODS
Preparation of Phosphorylating Mixture. Human platelet concentrates 1-7 days old were washed and stored as described (4). Platelet age did not influence the results described below. Frozen platelets were thawed and extracted in 0.6 M KCl-15 mM Tris HCl (pH 7.5)-5 mMt dithiothreitol-3% n-butanol at 40 for 45 min. The mixture was then centrifuged at 48,000 X g for 1 hr; the supernatant was made 0.1 M with respect to KCl by dilution with 2 mM MgSO4. The low ionic strength coupled with a lowering of the pH to 6.4 results in formation of a precipitate. This precipitate is collected by centrifugation for 10 min at 30,000 X g and washed overnight in 2 mM MgSO4-5 mM dithiothreitol (pH 6.4) . After a repeated centrifugation at 30,000 X g for 10 min the precipitate was solubilized in 0.6 M KCl-15 mM Tris HCl (pH 7.5)-5 mM dithiothreitol for 4-16 hr. The cloudy mixture is partially clarified by centrifugation at 30,000 X g for 30 min, and this supernatant was used for phosphorylation (protein concentration, 5-10 mg/ml).
Phosphorylation. Aliquots of the above mixture were made 50 mM with respect to NaF, and 'y-labeled AT32P was added to a final concentration of 7-200 ,M. Incubation times varied from 30 sec to 24 hr; however, incorporation was maximal at 20-50 min. The temperature was 0°(in order to inhibit myosin ATPase activity) and the pH was 7.5. In some experiments ['y-32P]ATP was added during the initial extraction of the platelets.
Phosphorylation was terminated by boiling the aliquot for 5 min in 5% sodium dodecyl sulfate, by gel filtration on Sepharose 4B (see Fig. 1 2.5 X 90-cm column. The column was eluted at 25 ml/hr. 7-ml Fractions were collected of which 0.2-ml aliquots were used for ATPase assay and radioactive counting. The AT32P in this experiment was added during the initial platelet extraction step.
Proc. Nat. Acad. Sci. USA 70 (1973) min or by incubating them in 8 M urea-50 mM dithiothreitol at 370 for 30 min. Gels were stained in 0.02% Coomassie brilliant blue dissolved in 10% acetic acid and 30% methanol, destained in 10% acetic acid and 30% methanol with the addition of Dowex 1-X 8 granules, and stored in 5% acetic acid.
For determination of the approximate location and quantitation of the amount of 82p in a gel, the unstained 6.6-cm gel was crushed and fractionated into 28-31 vials with a Savant Autogel divider; the resulting fractions were counted in a Packard Tri-Carb scintillation counter with Aquasol (New England Nuclear Corp.) as a solvent. The exact location of radioactivity was determined by cutting out bands from previously stained gels and crushing them with a glass rod before counting.
Purification of Myosin Light Chains. A mixture of platelet actomyosin and tropomyosin was reduced and alkylated in 5 M guanidine hydrochloride and 25 mM dithiothreitol with l4C]iodoacetamide as described (9) . After dialysis against 50 mM NH4HCO3, the actin and myosin heavy chains precipitated. In some cases they were removed by centiifugation and the supernatant, containing tropomyosin and light chains, was chromotographed on a 2.5 X 212-cm column of Sephadex G-75 in 10% propionic acid. Alternately the mixture (including actin and heavy chains) was lyophilized, solubilized in 90% propionic acid, and chromatographed on Sephadex G-100. Final purification of the light chains was propionic acid. Protein concentrations were determined by the procedure of Lowry et al. (10) . ATPase activity of the column fractions ( Figs. 1 and 2 ) was assayed at 1 hr as described (4) . Urea and guanidine hydrochloride were Ultrapure quality from Schwarz. All other materials were reagent grade. Deionized water was used throughout. RESULTS
Actomyosin can be purified from the preparation used for phosphorylation by chromatography on Sepharose 4B (Figs.  1 and 5) . The purified actomyosin is eluted at the void volume since all the myosin (both the intact molecule and the head fragment) is bound to large polymers of platelet actin. This peak of actomyosin contains both ATPase activity (due to myosin) and 32p radioactivity. The only other peak of radioactivity in Fig. 1 is due to unincorporated AT32P eluted at the salt boundary. If the sample is dialyzed against the column buffer before gel filtration, this second peak of radioactivity is eliminated. Fig. 2 shows the results of treating phosphorylated actomyosin with 10 mM ATP-MgCl2 and sedimenting the polymerized actin before applying the sample to the column (see ref. 4 for details). Under these circumstances actin (which possesses no radioactive label) is removed from the preparation and two peaks of ATPase activity, both of which are radioactive, are eluted from the column. The initial peak of ATPase activity is due to the intact myosin molecule, and the second peak is due to the head portion of the myosin molecule. The latter is a proteolytic fragment similar to skeletal-muscle myosin subfragment-1, having a molecular weight substantially lower than the intact molecule but retaining the enzymic and actin-binding properties of the intact molecule (4). The third peak of radioactivity is again a nonprotein peak due to free AT32P. Fig. 3 shows the pattern obtained by scanning a 10% acrylamide gel at A54 after electrophoresis of the purified actomyosin pooled from the initial peak in Fig. 1 . Superimposed on the scan is the pattern of 32p radioactivity eluted by crushing a companion gel and counting the various fractions. The single band of radioactivity was found to consistently electrophorese with the 20,000 molecular weight light chain of myosin both in Na dodecyl sulfate-acrylamide and in 8 M urea-acrylamide gels.
The finding that a peak of radioactivity consistently eluted with the myosin ATPase activity, whether myosin was bound to actin (Fig. 1) or not (Fig. 2) , suggested that one of the myosin chains was being phosphorylated. Further evidence that one of the myosin chains was being phosphorylated was obtained by addition of rabbit skeletalmuscle actin to a phosphorylated preparation that had been purified so as to remove platelet actin. When 5 mM ATP-5 mM MgCl2 was added along with the rabbit actin and the mixture was centrifuged at 100,000 X g for 1 hr, the supernatant possessed all the myosin ATPase activity. A Na dodecyl sulfate-polyacrylamide gel electrophoresis of the supernatant contained a single band of radioactivity, associated with a myosin light chain (results similar to Fig. 3 ). When ATP was not added along with the muscle actin, the actin bound to the platelet myosin and sedimented on centrifugation. The activity and the gel electrophoresis of the supernatant contained neither myosin light chain nor radioactivity. These experiments indicated that a light chain of platelet myosin was being phosphorylated.
Evidence that a myosin light chain was the only soluble protein phosphorylated is as follows: (1) 7'/2% and 10% polyacrylamide gels in both 1% Na dodecyl sulfate and 8 M urea (see Figs. 3 and 4) contained only a single band of radioactivity which coelectrophoresed with the 20,000 molecular weight light chain of platelet myosin. (2) Over 85% of the radioactivity that survived boiling and dialysis in Na dodecyl sulfate (from a sample of the initial peak from the Sepharose column in Fig. 1 ) was recovered in the single peak of radioactivity eluted from the Na dodecyl sulfateacrylamide gel (Fig. 3) . (3) If AT32P was added during the initial extraction of the platelets (Fig. 2) , the myosin light chain was still the only protein phosphorylated. Perrie et al. (11) have reported that an 18,500 molecular weight light chain of skeletal-muscle myosin can be phosphorylated with a protein kinase. It was of interest to see if the phosphorylated platelet and muscle light chains were similar with respect to their mobility in 8 M urea-acrylamide gels and amino-acid composition. Fig. 4 shows that both platelet myosin light chains migrate as a single band but with a more negative charge than any of three muscle myosin light chains in 8 M urea-acrylamide gels.
The two platelet light chains were separated and purified as described above. Fig. 5 shows Na dodecyl sulfate-acrylamide gels before and after purification of the light chains.
Amino-acid analysis of the purified phosphorylated light chain (unpublished results, this laboratory) showed it to be different from the 18,500 molecular weight light chain from skeletal muscle.
The manner in which B2p was bound to the platelet light chain was studied by incubating the light chains in alkali and acid (Fig. 6 ). The release of counts after incubation in alkali suggests that the 32p is covalently bound to either a serine or threonine residue through an ester linkage.
The ability to phosphorylate platelet myosin light chain is not inherent in the myosin molecule but is controlled by a kinase. Evidence for this is as follows: Purified myosin prepared either by gel filtration or ammonium sulfate fractionation (30-50% fraction) no longer possesses the ability to incorporate AT32P. However the 50-70% ammonium sulfate fraction, which does not contain myosin light chain, retains the ability to incorporate AT32P into a nonprotein acceptor and presumably contains the kinase responsible for phosphorylating platelet myosin.
Incorporation of 32p into the light chain of myosin was measured by comparing the counts recovered from a crushed gel to an estimate, based on the Lowry protein assay of the actomyosin concentration, of the milligrams of light chain applied to the gel. With an AT32P concentration of 0.2 mM, 0.7-1 mol Of 32p was incorporated per mol of light chain, assuming the presence of 2 mol of phosphorylated light chain per mol of myosin. We do not know whether this incorporation is unique to a single amino-acid residue of the light chain as is the case for muscle myosin (21) . DISCUSSION Recent reports from several laboratories have been concerned with the phosphorylation of skeletal-muscle contractile proteins. Stull et al. (12) used phosphorylase kinase to phosphorylate rabbit skeletal-muscle troponin I, and England et al. (13) showed that phosphorylated troponin-I could be The mechanism by which phosphorylation influences actin-myosin interaction in cells can only be speculated on. In platelets, phosphorylation, either together with or in place of the troponins, may play a role in initiating or preventing the interaction of myosin and actin. Since it is now apparent that both myosin and actin are present not only in platelets but in numerous other cells including nerve, brain, (16, 17) and fibroblasts (18, 19) , it is possible that control of all cellular contraction may be mediated by phosphorylation. Finally, since numerous hormones and drugs influence cell motility and aggregation and since platelets contain adenyl cyclase (20) , it will be of interest to see if the phosphorylation of platelet myosin is influenced by the rapid flux in the levels of cyclic AMP that occurs during physiologic responses of platelets.
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